About HTS Biopharma
HTS Biopharma is a Healthcare company based in Hyderabad (India) founded in 2012. It manufactures API impurities, reference standards, and offers custom synthesis services. It operates on a B2B model in Healthcare and Chemicals & Materials sectors. Its Indian entity Hts Biopharma Private Limited reported revenue of ₹6.71 Cr. HTS Biopharma offers products and services including API Impurities, API Intermediates, Fine Chemicals, Carbohydrates, and Prostaglandins and Vitamin. Its focus areas include Pharmaceutical Manufacturing, API and Impurities, Reference Standards and Chemicals.
Company details
HTS Biopharma, established in 2012, is a leading manufacturer and supplier of impurity reference standards, API standards, process impurities, metabolites, building blocks, and biomolecules in Hyderabad, India. They provide custom synthesis and contract manufacturing services using advanced analytical instruments to ensure quality. Serving pharmaceutical industries, they focus on research, product development, and outsourcing partnerships for strategic products.
- Headquarters Hyderabad, India
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website htsbiopharma.com
- Legal Name Hts Biopharma Private Limited
- Date of Incorporation 16 Apr, 2012
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹6.71 Cr
FY 2024 · +7% YoY
- Net Profit₹50 Lakh
FY 2024 · 7% margin
- EBITDA₹88.9 Lakh
FY 2024 · 13% margin
Associated legal entities of HTS Biopharma
HTS Biopharma operates through Hts Biopharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hts Biopharma Private Limited CIN U24232TG2012PTC080323 | Active | 16 Apr 2012 | Hyderabad, Telangana | ₹6.7 Cr | 3 | View details |
Products & Services of HTS Biopharma
HTS Biopharma offers a comprehensive portfolio of products and services, including API Impurities, API Intermediates, Fine Chemicals, Carbohydrates, and Prostaglandins and Vitamin.
Reference standards for detecting impurities in APIs
Compounds used in API synthesis processes
High-purity chemicals for research applications
Organic compounds for pharmaceutical development
Specialized molecules for drug manufacturing
Board of directors of Hts Biopharma Private Limited (HTS Biopharma)
Hts Biopharma Private Limited is the primary company behind HTS Biopharma. The board of Hts Biopharma Private Limited currently have 3 directors; the longest-serving is Neelima Veldi, appointed in 2013. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Neelima Veldi DIN 06698256 | Director | 21 Sep 2013 | 13 yrs 1 mo | Hts Biopharma Private Limited |
| Srinivas Reddy Chaduvu DIN 05201779 | Director | 20 Jan 2017 | 9 yrs 9 mo | Hts Biopharma Private Limited |
| Surendar Velagapuri DIN 05206482 | Director | 20 Jan 2017 | 9 yrs 9 mo | Hts Biopharma Private Limited |
Financials of HTS Biopharma
Figures of Hts Biopharma Private Limited, the primary company behind HTS Biopharma, for FY 2024. Revenue was ₹6.71 Cr (+7% year on year). Net profit was ₹50 Lakh (7% margin). EBITDA was ₹88.9 Lakh (13% margin). Revenue has grown at a compounded annual rate of +6% over three years and +9% over five years.
- ₹6.71 CrRevenue · FY 2024 · +7% YoY
- ₹50 LakhNet profit · 7% margin
- ₹88.9 LakhEBITDA · 13% margin
- ₹9 LakhPaid-up capital
- +6%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Hts Biopharma Private Limited are on its company page.
Detailed financial statements for HTS Biopharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about HTS Biopharma
HTS Biopharma was founded in 2012.
HTS Biopharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind HTS Biopharma, Hts Biopharma Private Limited, reported revenue of ₹6.71 Cr for FY 2024, up 7% year on year.
HTS Biopharma, established in 2012, is a leading manufacturer and supplier of impurity reference standards, API standards, process impurities, metabolites, building blocks, and biomolecules in Hyderabad, India. They provide custom synthesis and contract manufacturing services using advanced analytical instruments to ensure quality. Serving pharmaceutical industries, they focus on research, product development, and outsourcing partnerships for strategic products.
HTS Biopharma offers API Impurities, API Intermediates, Fine Chemicals, Carbohydrates, and Prostaglandins and Vitamin.
HTS Biopharma operates through Hts Biopharma Private Limited.
The legal entities of HTS Biopharma currently have 3 directors, including Srinivas Reddy Chaduvu, Surendar Velagapuri, Neelima Veldi.